Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02215148 · ClinicalTrials.gov registry record
Pharmacokinetics and Clinical Response of Tolvaptan in Neurocritical Care Patients
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Terminated
- Registry status
- 1
- Enrollment target
NCT02215148 is a clinical trial that was terminated before completion, run by University of North Carolina, Chapel Hill. The registered enrollment target is 1 participants.
The verdict
NCT02215148 was terminated before completion, sponsored by University of North Carolina, Chapel Hill.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
To assess the pharmacokinetic profile of tolvaptan in critically ill acute brain injury patients and to secondarily evaluate the clinical response and safety of tolvaptan in acute brain injured patients
Interventions
- DRUG Tolvaptan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2014-11 |
| Est. Completion | 2016-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02215148
The ClinicalTrials.gov registry entry for NCT02215148 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tolvaptan is the first listed.
NCT02215148 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02215148 about?
NCT02215148 is a clinical study titled "Pharmacokinetics and Clinical Response of Tolvaptan in Neurocritical Care Patients". To assess the pharmacokinetic profile of tolvaptan in critically ill acute brain injury patients and to secondarily evaluate the clinical response and safety of tolvaptan in acute brain injured patients
What is the current status of trial NCT02215148?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2014-11. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02215148?
The interventions under investigation include: Tolvaptan (DRUG).
Who is sponsoring clinical trial NCT02215148?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.